[Inducement effect of (DIPP-L-Trp)2-L-Lys-OCH3 on apoptosis of K562 cells through mitochondrial-dependent pathway]

Feng Liu1, Yu-Yang Jiang, Shi-Ying Liu

  • 1Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, 100084, P. R. China.

Abstract

Insights

This study shows that (O,O-diisopropyl phosphoryl-L-tryptophan)(2)-L-lysine methyl ester induces apoptosis in K562 cancer cells. The mechanism involves reduced mitochondrial membrane potential and decreased reactive oxygen species production.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Context:

  • Protein and peptide phosphorylation is vital for cellular functions.
  • Certain phosphorylated peptides exhibit anti-tumor properties, but their mechanisms remain unclear.
  • Investigating novel compounds for cancer therapy is crucial.

Purpose:

  • To investigate the mechanism of apoptosis induced by (O,O-diisopropyl phosphoryl-L-tryptophan)(2)-L-lysine methyl ester [(DIPP-L-Trp)(2)-L-Lys-OCH(3)] in K562 cells.
  • To determine the role of mitochondrial membrane potential (Delta Psi m) and reactive oxygen species (ROS) in this process.

Summary:

  • Treatment of K562 cells with (DIPP-L-Trp)(2)-L-Lys-OCH(3) resulted in a significant increase in apoptosis (61.9% at 50 microg/ml for 24 h).
  • The compound induced a decrease in mitochondrial membrane potential (Delta Psi m) in 93.6% of cells.
  • Both Delta Psi m and ROS production were dose- and time-dependently reduced by (DIPP-L-Trp)(2)-L-Lys-OCH(3).

Impact:

  • This research elucidates a potential mechanism for the anti-cancer activity of (DIPP-L-Trp)(2)-L-Lys-OCH(3).
  • Findings suggest that targeting mitochondrial function and ROS levels could be a viable strategy in cancer treatment.
  • Provides a foundation for further investigation into phosphopeptide-based cancer therapeutics.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...